Abstract
Many neurodegenerative diseases are associated with the formation of insoluble structures composed primarily of protein aggregates. Examples include Alzheimer disease (neurofibrillary tangles and amyloid plaques), Parkinson disease (Lewy bodies), and a class of diseases provoked by extension of the length of polyglutamine (polyQ) sequences in particular proteins. The extended polyQ sequences result from abnormal expansion of CAG repeats in the genes encoding the affected proteins, and they are thus inherited. In this issue, Popiel et al.1 tested a new therapeutic strategy to treat a Drosophila model of polyQ disease that involves feeding to the flies a fusion peptide designed to disrupt polyQ aggregates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
